Cantor Fitzgerald analyst Sarah James upgraded Universal Health to Neutral from Underweight with a price target of $219, up from $162. The firm believes the bear case has been overweighed in the valuation and is incrementally bullish on the acute segment, the analyst tells investors in a research note. At the same time, the firm remains concerned that the labor shortage in psych could intensify over time given the wage differential to acute and retirement cycle.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- UHS Earnings: Universal Health Jumps after Huge EPS, Guidance Beats
- UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES 2024 SECOND QUARTER FINANCIAL RESULTS, INCREASES 2024 FULL YEAR OPERATING RESULTS FORECAST AND ANNOUNCES $1 BILLION INCREASE TO STOCK REPURCHASE PROGRAM AUTHORIZATION
- Universal Health raises FY24 adjusted EPS view to $15.40-$16.20
- Universal Health reports Q2 adjusted EPS $4.31, consensus $3.28
- Notable companies reporting after market close